C. S. Mosgaard

Most-cited papers

1. Interval-Walking Improves Glycaemic Control and Body Composition after Cancer Treatment: A Randomized Controlled Trial.

   J. Christensen, A. Sundberg, J. T. F. Osterkamp, Sarah Thorsen-Streit +13 more

   2019Journal of Clinical Endocrinology and Metabolism18 citations Open access

   Semantic Scholar

   Save

2. The prognostic role of circulating CA19-9 and CEA in patients with colorectal cancer.

   M. H. Gramkow, C. S. Mosgaard, J. Schou, Ellen Hein Nordvig +10 more

   2025Cancer Treatment and Research Communications13 citations Open access

   Semantic Scholar

   Save

3. The “Interval Walking in Colorectal Cancer” (I-WALK-CRC) study: Design, methods and recruitment results of a randomized controlled feasibility trial

   Anna Banck-Petersen, C. K. Olsen, S. Djurhuus, A. Herrstedt +10 more

   2018Contemporary Clinical Trials Communications10 citations Open access

   Semantic Scholar

   Save

4. The prognostic value of serum CA 19-9 in patients with metastatic colorectal cancer.

   C. S. Mosgaard, M. H. Gramkow, C. Dehlendorff, D. Nielsen +9 more

   20171 citations

   Semantic Scholar

   Save

5. Long-term outcomes after heparin versus low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism - a secondary analysis of the STRATIFY randomized controlled trial.

   E. Sonne-Holm, L. Bang, J. Carlsen, M. Winther-Jensen +11 more

   2026Journal of Thrombosis and Haemostasis0 citations

   Semantic Scholar

   Save

6. The prognostic value of serum IL-6 and YKL-40 in patients with metastatic colorectal cancer.

   B. Jensen, M. H. Gramkow, C. S. Mosgaard, C. Dehlendorff +9 more

   20170 citations

   Semantic Scholar

   Save